Published in Br J Radiol on February 01, 1977
Hyperthermia in cancer therapy: where are we today and where are we going? Bull N Y Acad Med (1992) 0.78
Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest (2001) 23.21
Regulation of simian virus 40 early transcription in vitro by a purified tumor antigen. Proc Natl Acad Sci U S A (1980) 10.22
Simplified reference tissue model for PET receptor studies. Neuroimage (1996) 8.28
Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet (1993) 6.53
Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill (2012) 4.96
Area V5 of the human brain: evidence from a combined study using positron emission tomography and magnetic resonance imaging. Cereb Cortex (1993) 4.79
Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage (1997) 4.13
In-vivo measurement of activated microglia in dementia. Lancet (2001) 3.51
Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys (1996) 3.42
Elevating clinical licensing examinations to professional testing standards. N Y State Dent J (1998) 3.20
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain (2000) 2.84
The Huntington's disease candidate region exhibits many different haplotypes. Nat Genet (1992) 2.84
Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab (1996) 2.66
The relative effects of fast neutrons and x rays on tumour and normal tissue in the rat. II. Fractionation: recovery and reoxygenation. Br J Radiol (1968) 2.09
Artifacts due to stimulus correlated motion in functional imaging of the brain. Magn Reson Med (1994) 1.99
Changes in relative biological effectiveness with depth of the Clatterbridge neutron therapy beam. Br J Radiol (1988) 1.91
Balancing justice and autonomy in clinical research with healthy volunteers. Clin Pharmacol Ther (2007) 1.68
Early and late reactions in skin of rats following irradiation with x-rays or fast neutrons. Radiology (1969) 1.66
Experimental increase in accommodative potential after neodymium: yttrium-aluminum-garnet laser photodisruption of paired cadaver lenses. Ophthalmology (2001) 1.64
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41. Antimicrob Agents Chemother (2005) 1.63
Familial history of stroke and stroke risk. The Family Heart Study. Stroke (1997) 1.61
Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage (1998) 1.59
Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide. Br J Cancer (1981) 1.54
Hyperthermia in the treatment of cancer. Cancer Treat Rev (1979) 1.49
PK ('peripheral benzodiazepine')--binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J Neurocytol (1997) 1.49
The Ellis formulae for x rays and fast neutrons. Br J Radiol (1972) 1.49
Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology (2000) 1.47
The design and physical characteristics of a small animal positron emission tomograph. Phys Med Biol (1995) 1.44
Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome. Am J Psychiatry (1990) 1.43
Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl Med Biol (1994) 1.43
Repair of radiation damage in Lewis lung carcinoma cells following in situ treatment with fast neutrons and gamma-rays. Cancer Res (1975) 1.42
Human immunodeficiency virus. Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex. J Biol Chem (1996) 1.39
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
Extracorporeal whole body hyperthermia treatment of HIV patients, a feasibility study. Int J Hyperthermia (1998) 1.38
[11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology (1999) 1.36
Use of cancer susceptibility testing among primary care physicians. Clin Genet (2003) 1.30
In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain (2001) 1.26
Genome scan for quantity of hand osteoarthritis: the Framingham Study. Arthritis Rheum (2002) 1.25
Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect (2010) 1.23
Effect of growth in lithium on ouabain binding, Na-K-ATPase and Na and K transport in hela cells. J Physiol (1975) 1.22
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology (2003) 1.22
Nerve compression injury and increased endoneurial fluid pressure: a "miniature compartment syndrome". J Neurol Neurosurg Psychiatry (1983) 1.20
1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers. Neurology (1998) 1.20
Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse (1992) 1.20
Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons. Int J Radiat Oncol Biol Phys (1977) 1.16
Endpoints for damage to normal tissues. Int J Radiat Oncol Biol Phys (1979) 1.15
Effects of fractionated irradiation on mouse lung and a phenomenon of slow repair. Br J Radiol (1976) 1.13
Assessment of spatial normalization of PET ligand images using ligand-specific templates. Neuroimage (1999) 1.12
Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses. Gene Ther (2012) 1.12
Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes Brain Behav (2007) 1.12
The Next Step Trial: impact of a worksite colorectal cancer screening promotion program. Prev Med (1999) 1.11
Radiobiological aspects of fast neutron therapy. Proc R Soc Med (1972) 1.09
Induced thermal resistance in the mouse ear. Br J Radiol (1979) 1.08
An investigation into the clinical effects of fast neutrons. Methods and early observations. Br J Radiol (1971) 1.08
Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model. Cancer Gene Ther (2006) 1.07
Rate-dependent changes of twitch force duration in rat cardiac trabeculae: a property of the contractile system. J Physiol (2000) 1.06
Compartmental analysis of diprenorphine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro. J Cereb Blood Flow Metab (1991) 1.05
The treatment of hemorrhagic shock. Surg Gynecol Obstet (1966) 1.05
The relationship between heating time and temperature: its relevance to clinical hyperthermia. Radiother Oncol (1983) 1.05
The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent. Q J Nucl Med Mol Imaging (2007) 1.04
Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury. Neuroreport (2001) 1.04
Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis nd PET after fenfluramine. Synapse (2001) 1.03
Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. Eur J Pharmacol (1996) 1.03
The multidisciplinary clinic approach to prostate cancer counseling and treatment. Semin Urol Oncol (2000) 1.02
Visual attention impairments in Alzheimer's disease. Neurology (2000) 1.00
Vascular permeability and late radiation fibrosis in mouse lung. Radiat Res (1985) 1.00
Monitoring by PET of macrophage accumulation in brain after ischaemic stroke. Lancet (1992) 0.99
Nutrition intervention for high-risk auto workers: results of the Next Step Trial. Prev Med (1999) 0.99
The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. J Neurosci Methods (1996) 0.98
In vivo binding to peripheral benzodiazepine binding sites in lesioned rat brain: comparison between [3H]PK11195 and [18F]PK14105 as markers for neuronal damage. J Neurochem (1990) 0.98
[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo. Eur J Nucl Med (1998) 0.97
The relationship between heating time and temperature for rat tail necrosis with and without occlusion of the blood supply. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 0.97
Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials. Cancer Res (1997) 0.97
Blood alcohol and fat embolism syndrome. J Bone Joint Surg Am (1977) 0.96
The energy metabolism of RIF-1 tumours following hydralazine. Radiother Oncol (1990) 0.96
The effect of oxygen on impairment of the proliferative capacity of human cells in culture by ionizing radiations of different LET. Int J Radiat Biol Relat Stud Phys Chem Med (1966) 0.96
Damage to mouse lung with neutrons and x-rays. Eur J Cancer (1974) 0.94
Non-invasive molecular imaging of beta-adrenoceptors in vivo: perspectives for PET-radioligands. Curr Med Chem (2005) 0.94
Effects of neutron and X irradiation on cell proliferation in mouse lung. Radiat Res (1981) 0.93
The relative effects of fast neutrons and x rays on tumour and normal tissue in the rat. I. Single doses. Br J Radiol (1967) 0.93
Dynamics of multiple myeloma tumor therapy with a recombinant measles virus. Cancer Gene Ther (2009) 0.93
Evaluation of biomarker modulation by fenretinide in prostate cancer patients. Eur Urol (1999) 0.92
Genome sequence analysis of Ebola virus in clinical samples from three British healthcare workers, August 2014 to March 2015. Euro Surveill (2015) 0.92
The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen. J Urol (2001) 0.92
Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET. J Neural Transm (Vienna) (1998) 0.92
Fractionation with x rays and neutrons in mice: response of skin and C 3 H mammary tumours. Br J Radiol (1972) 0.91
The influence of blood flow on temperature distribution in the exteriorized mouse intestine during treatment by hyperthermia. Br J Radiol (1979) 0.91
High-resolution physical and transcriptional mapping of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy locus on chromosome 21q22.3 by FISH. Genome Res (1997) 0.91
Worksite cancer screening and nutrition intervention for high-risk auto workers: design and baseline findings of the Next Step Trial. Prev Med (1997) 0.90
Treatment of functional menorrhagia by radiofrequency-induced thermal endometrial ablation. Lancet (1990) 0.90
Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511). AIDS (2001) 0.90
A microwave heating system for improving temperature uniformity in heated tissue. J Microw Power (1979) 0.89
Histological, laboratory, and X-ray findings after repair of the common bile duct with a Teflon graft. Invited commentary. World J Surg (1978) 0.89